Global Sickle Cell Anemia Drug Market Research Report 2016

November 2016 | 100 pages | ID: G8866ED3C54EN
QYResearch

Abstracts

Notes:

Production, means the output of Sickle Cell Anemia Drug

Revenue, means the sales value of Sickle Cell Anemia Drug

This report studies Sickle Cell Anemia Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• GlycoMimetics
• Bluebird bio
• GlaxoSmithKline
• Mast Therapeutics
• Bayer AG
• Eli Lilly
• Regen biopharma

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Sickle Cell Anemia Drug in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Sickle Cell Anemia Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Sickle Cell Anemia Drug Market Research Report 2016

1 SICKLE CELL ANEMIA DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Sickle Cell Anemia Drug
1.2 Sickle Cell Anemia Drug Segment by Type
  1.2.1 Global Production Market Share of Sickle Cell Anemia Drug by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Sickle Cell Anemia Drug Segment by Application
  1.3.1 Sickle Cell Anemia Drug Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Sickle Cell Anemia Drug Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Sickle Cell Anemia Drug (2011-2021)

2 GLOBAL SICKLE CELL ANEMIA DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Sickle Cell Anemia Drug Production and Share by Manufacturers (2015 and 2016)
2.2 Global Sickle Cell Anemia Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Sickle Cell Anemia Drug Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Sickle Cell Anemia Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Sickle Cell Anemia Drug Market Competitive Situation and Trends
  2.5.1 Sickle Cell Anemia Drug Market Concentration Rate
  2.5.2 Sickle Cell Anemia Drug Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL SICKLE CELL ANEMIA DRUG PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Sickle Cell Anemia Drug Production and Market Share by Region (2011-2016)
3.2 Global Sickle Cell Anemia Drug Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL SICKLE CELL ANEMIA DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Sickle Cell Anemia Drug Consumption by Regions (2011-2016)
4.2 North America Sickle Cell Anemia Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Sickle Cell Anemia Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Sickle Cell Anemia Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Sickle Cell Anemia Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Sickle Cell Anemia Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Sickle Cell Anemia Drug Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL SICKLE CELL ANEMIA DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Sickle Cell Anemia Drug Production and Market Share by Type (2011-2016)
5.2 Global Sickle Cell Anemia Drug Revenue and Market Share by Type (2011-2016)
5.3 Global Sickle Cell Anemia Drug Price by Type (2011-2016)
5.4 Global Sickle Cell Anemia Drug Production Growth by Type (2011-2016)

6 GLOBAL SICKLE CELL ANEMIA DRUG MARKET ANALYSIS BY APPLICATION

6.1 Global Sickle Cell Anemia Drug Consumption and Market Share by Application (2011-2016)
6.2 Global Sickle Cell Anemia Drug Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL SICKLE CELL ANEMIA DRUG MANUFACTURERS PROFILES/ANALYSIS

7.1 GlycoMimetics
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Sickle Cell Anemia Drug Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 GlycoMimetics Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Bluebird bio
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Sickle Cell Anemia Drug Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Bluebird bio Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 GlaxoSmithKline
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Sickle Cell Anemia Drug Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 GlaxoSmithKline Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Mast Therapeutics
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Sickle Cell Anemia Drug Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Mast Therapeutics Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Bayer AG
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Sickle Cell Anemia Drug Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Bayer AG Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Eli Lilly
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Sickle Cell Anemia Drug Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Eli Lilly Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Regen biopharma
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Sickle Cell Anemia Drug Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Regen biopharma Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview

8 SICKLE CELL ANEMIA DRUG MANUFACTURING COST ANALYSIS

8.1 Sickle Cell Anemia Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Sickle Cell Anemia Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Sickle Cell Anemia Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Sickle Cell Anemia Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL SICKLE CELL ANEMIA DRUG MARKET FORECAST (2016-2021)

12.1 Global Sickle Cell Anemia Drug Production, Revenue Forecast (2016-2021)
12.2 Global Sickle Cell Anemia Drug Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Sickle Cell Anemia Drug Production Forecast by Type (2016-2021)
12.4 Global Sickle Cell Anemia Drug Consumption Forecast by Application (2016-2021)
12.5 Sickle Cell Anemia Drug Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Sickle Cell Anemia Drug
Figure Global Production Market Share of Sickle Cell Anemia Drug by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Sickle Cell Anemia Drug Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Sickle Cell Anemia Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Sickle Cell Anemia Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Sickle Cell Anemia Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Sickle Cell Anemia Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Sickle Cell Anemia Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Sickle Cell Anemia Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Sickle Cell Anemia Drug Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Sickle Cell Anemia Drug Production of Key Manufacturers (2015 and 2016)
Table Global Sickle Cell Anemia Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Sickle Cell Anemia Drug Production Share by Manufacturers
Figure 2016 Sickle Cell Anemia Drug Production Share by Manufacturers
Table Global Sickle Cell Anemia Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Sickle Cell Anemia Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Sickle Cell Anemia Drug Revenue Share by Manufacturers
Table 2016 Global Sickle Cell Anemia Drug Revenue Share by Manufacturers
Table Global Market Sickle Cell Anemia Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Sickle Cell Anemia Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Sickle Cell Anemia Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Sickle Cell Anemia Drug Product Type
Figure Sickle Cell Anemia Drug Market Share of Top 3 Manufacturers
Figure Sickle Cell Anemia Drug Market Share of Top 5 Manufacturers
Table Global Sickle Cell Anemia Drug Production by Regions (2011-2016)
Figure Global Sickle Cell Anemia Drug Production and Market Share by Regions (2011-2016)
Figure Global Sickle Cell Anemia Drug Production Market Share by Regions (2011-2016)
Figure 2015 Global Sickle Cell Anemia Drug Production Market Share by Regions
Table Global Sickle Cell Anemia Drug Revenue by Regions (2011-2016)
Table Global Sickle Cell Anemia Drug Revenue Market Share by Regions (2011-2016)
Table 2015 Global Sickle Cell Anemia Drug Revenue Market Share by Regions
Table Global Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table China Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table India Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Sickle Cell Anemia Drug Consumption Market by Regions (2011-2016)
Table Global Sickle Cell Anemia Drug Consumption Market Share by Regions (2011-2016)
Figure Global Sickle Cell Anemia Drug Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Sickle Cell Anemia Drug Consumption Market Share by Regions
Table North America Sickle Cell Anemia Drug Production, Consumption, Import & Export (2011-2016)
Table Europe Sickle Cell Anemia Drug Production, Consumption, Import & Export (2011-2016)
Table China Sickle Cell Anemia Drug Production, Consumption, Import & Export (2011-2016)
Table Japan Sickle Cell Anemia Drug Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Sickle Cell Anemia Drug Production, Consumption, Import & Export (2011-2016)
Table India Sickle Cell Anemia Drug Production, Consumption, Import & Export (2011-2016)
Table Global Sickle Cell Anemia Drug Production by Type (2011-2016)
Table Global Sickle Cell Anemia Drug Production Share by Type (2011-2016)
Figure Production Market Share of Sickle Cell Anemia Drug by Type (2011-2016)
Figure 2015 Production Market Share of Sickle Cell Anemia Drug by Type
Table Global Sickle Cell Anemia Drug Revenue by Type (2011-2016)
Table Global Sickle Cell Anemia Drug Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Sickle Cell Anemia Drug by Type (2011-2016)
Figure 2015 Revenue Market Share of Sickle Cell Anemia Drug by Type
Table Global Sickle Cell Anemia Drug Price by Type (2011-2016)
Figure Global Sickle Cell Anemia Drug Production Growth by Type (2011-2016)
Table Global Sickle Cell Anemia Drug Consumption by Application (2011-2016)
Table Global Sickle Cell Anemia Drug Consumption Market Share by Application (2011-2016)
Figure Global Sickle Cell Anemia Drug Consumption Market Share by Application in 2015
Table Global Sickle Cell Anemia Drug Consumption Growth Rate by Application (2011-2016)
Figure Global Sickle Cell Anemia Drug Consumption Growth Rate by Application (2011-2016)
Table GlycoMimetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlycoMimetics Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlycoMimetics Sickle Cell Anemia Drug Market Share (2011-2016)
Table Bluebird bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bluebird bio Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bluebird bio Sickle Cell Anemia Drug Market Share (2011-2016)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Sickle Cell Anemia Drug Market Share (2011-2016)
Table Mast Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mast Therapeutics Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Mast Therapeutics Sickle Cell Anemia Drug Market Share (2011-2016)
Table Bayer AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer AG Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer AG Sickle Cell Anemia Drug Market Share (2011-2016)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Sickle Cell Anemia Drug Market Share (2011-2016)
Table Regen biopharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Regen biopharma Sickle Cell Anemia Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Regen biopharma Sickle Cell Anemia Drug Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sickle Cell Anemia Drug
Figure Manufacturing Process Analysis of Sickle Cell Anemia Drug
Figure Sickle Cell Anemia Drug Industrial Chain Analysis
Table Raw Materials Sources of Sickle Cell Anemia Drug Major Manufacturers in 2015
Table Major Buyers of Sickle Cell Anemia Drug
Table Distributors/Traders List
Figure Global Sickle Cell Anemia Drug Production and Growth Rate Forecast (2016-2021)
Figure Global Sickle Cell Anemia Drug Revenue and Growth Rate Forecast (2016-2021)
Table Global Sickle Cell Anemia Drug Production Forecast by Regions (2016-2021)
Table Global Sickle Cell Anemia Drug Consumption Forecast by Regions (2016-2021)
Table Global Sickle Cell Anemia Drug Production Forecast by Type (2016-2021)
Table Global Sickle Cell Anemia Drug Consumption Forecast by Application (2016-2021)